XBiotech Inc (XBIT)
8.16
+0.49
(+6.39%)
USD |
NASDAQ |
May 01, 16:00
8.20
+0.04
(+0.49%)
Pre-Market: 20:00
XBiotech Enterprise Value: 48.46M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 48.46M |
| April 30, 2024 | 33.54M |
| April 29, 2024 | 36.28M |
| April 26, 2024 | 39.63M |
| April 25, 2024 | 49.98M |
| April 24, 2024 | 45.72M |
| April 23, 2024 | 49.07M |
| April 22, 2024 | 42.06M |
| April 19, 2024 | 44.80M |
| April 18, 2024 | 40.84M |
| April 17, 2024 | 46.93M |
| April 16, 2024 | 72.82M |
| April 15, 2024 | 86.52M |
| April 12, 2024 | 81.65M |
| April 11, 2024 | 89.26M |
| April 10, 2024 | 101.14M |
| April 09, 2024 | 82.26M |
| April 08, 2024 | 96.26M |
| April 05, 2024 | 49.98M |
| April 04, 2024 | 85.61M |
| April 03, 2024 | 56.07M |
| April 02, 2024 | 57.90M |
| April 01, 2024 | 39.02M |
| March 28, 2024 | 47.54M |
| March 27, 2024 | 43.28M |
| Date | Value |
|---|---|
| March 26, 2024 | 42.67M |
| March 25, 2024 | 28.05M |
| March 22, 2024 | 28.36M |
| March 21, 2024 | 20.75M |
| March 20, 2024 | 18.01M |
| March 19, 2024 | 16.48M |
| March 18, 2024 | 1.866M |
| March 15, 2024 | -20.06M |
| March 14, 2024 | -6.444M |
| March 13, 2024 | -7.966M |
| March 12, 2024 | -7.357M |
| March 11, 2024 | -6.748M |
| March 08, 2024 | -5.226M |
| March 07, 2024 | -5.531M |
| March 06, 2024 | -5.226M |
| March 05, 2024 | -8.574M |
| March 04, 2024 | -5.531M |
| March 01, 2024 | -5.226M |
| February 29, 2024 | -9.487M |
| February 28, 2024 | -7.052M |
| February 27, 2024 | -5.531M |
| February 26, 2024 | -3.704M |
| February 23, 2024 | -3.704M |
| February 22, 2024 | -13.75M |
| February 21, 2024 | 9.992M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-458.09M
Minimum
Mar 16 2020
779.34M
Maximum
Dec 24 2019
102.56M
Average
104.33M
Median
Dec 21 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.654M |
| Palatin Technologies Inc | 20.69M |
| iBio Inc | 16.31M |
| Theriva Biologics Inc | -13.25M |
| Oragenics Inc | 2.992M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.635M |
| Total Expenses (Quarterly) | 8.587M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -10.05% |
| Normalized Earnings Yield | -12.34 |